Avion Wealth’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Avion Wealth’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-500	Closed	-$6K	–	820
2022 Q4	$6K	Hold	500	–	–	﹤0.01%	308
2022 Q3	$7K	Hold	500	–	–	﹤0.01%	301
2022 Q2	$7K	Hold	500	–	–	﹤0.01%	298
2022 Q1	$8K	Hold	500	–	–	﹤0.01%	259
2021 Q4	$8K	Hold	500	–	–	﹤0.01%	263
2021 Q3	$7K	Hold	500	–	–	﹤0.01%	263
2021 Q2	$10K	Hold	500	–	–	﹤0.01%	225
2021 Q1	$12K	Hold	500	–	–	﹤0.01%	208
2020 Q4	$12K	Hold	500	–	–	﹤0.01%	209
2020 Q3	$21K	Hold	500	–	–	0.01%	138
2020 Q2	$24K	Hold	500	–	–	0.01%	120
2020 Q1	$31K	Buy	+500	New	+$44.9K	0.01%	106

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Avion Wealth's ICPT Position: Q1 2023 in Review

Avion Wealth sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2023, closing a stake of 500 shares — an estimated $6K sold.

Avion Wealth first reported a position in ICPT in Q1 2020 and held it in 12 quarters. The position peaked at $31K in Q1 2020. 144 funds tracked by Wall St. Rank hold ICPT as of Q1 2023.

Avion Wealth reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Avion Wealth sold 500 Intercept Pharmaceuticals, Inc. shares in Q1 2023, an estimated $6K.
Avion Wealth first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2020 and held it in 12 quarters.
Avion Wealth's Intercept Pharmaceuticals, Inc. position peaked at $31K in Q1 2020.
144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2023.

Based on Avion Wealth's 13F filing for Q1 2023, filed 5 May 2023.